title: Adjuvants enhancing an integral immune response to antigens. 15-17 September, 2004, Modern Vaccine/Adjuvant Formulation: impact on future development (MVAF 2004), Prague.
authors.affiliation: National Institute for Public Health and the Environment, Centre for Biological Medicines and Medical Technology, The Netherlands. jan-willem.van.der.laan@rivm.nl
authors.forename: Jan Willem
authors.initials: JW
authors.lastname: van der Laan
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage* / Q000627:therapeutic use; D000818:Animals; D000941:Antigens / Q000276:immunology*; D001424:Bacterial Infections / Q000188:drug therapy / Q000276:immunology; D001428:Bacterial Vaccines / Q000008:administration & dosage* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D016503:Drug Delivery Systems; D015195:Drug Design; D004353:Drug Evaluation, Preclinical; D006801:Humans; D008081:Liposomes; D051193:Toll-Like Receptors / Q000276:immunology; D019444:Vaccines, DNA / Q000008:administration & dosage / Q000627:therapeutic use; D014614:Vaccines, Synthetic / Q000008:administration & dosage / Q000627:therapeutic use; D022701:Virosomes
chemical_list: D000276:Adjuvants, Immunologic; D000941:Antigens; D001428:Bacterial Vaccines; D008081:Liposomes; D051193:Toll-Like Receptors; D019444:Vaccines, DNA; D014614:Vaccines, Synthetic; D022701:Virosomes